SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-21-028002
Filing Date
2021-08-12
Accepted
2021-08-12 07:16:03
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10027884_10q.htm   iXBRL 10-Q 952605
2 EXHIBIT 31.1 brhc10027884_ex31-1.htm EX-31.1 12603
3 EXHIBIT 31.2 brhc10027884_ex31-2.htm EX-31.2 12104
4 EXHIBIT 32.1 brhc10027884_ex32-1.htm EX-32.1 5419
5 EXHIBIT 32.2 brhc10027884_ex32-2.htm EX-32.2 5227
11 image00002.jpg GRAPHIC 26565
  Complete submission text file 0001140361-21-028002.txt   4442599

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20210630.xsd EX-101.SCH 31843
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20210630_cal.xml EX-101.CAL 31686
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20210630_def.xml EX-101.DEF 116614
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20210630_lab.xml EX-101.LAB 464183
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20210630_pre.xml EX-101.PRE 248813
12 EXTRACTED XBRL INSTANCE DOCUMENT brhc10027884_10q_htm.xml XML 636529
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 211165491
SIC: 2834 Pharmaceutical Preparations